Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
06-08 June, 2025
Not Confirmed
Not Confirmed
09-11 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
06-08 June, 2025
Industry Trade Show
Not Confirmed
09-11 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
05 Jun 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250605276377/en/Tracer-Biotechnologies-Announces-Strategic-Partnership-with-QIAGEN-to-Advance-Blood-Based-MRD-Testing-for-Solid-Tumors
22 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250522348645/en/QIAGEN-expands-digital-PCR-oncology-research-portfolio-through-partnership-with-ID-Solutions
07 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250507719506/en/QIAGEN-announces-plans-for-transition-in-leadership-of-Supervisory-Board
07 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250507039488/en/QIAGEN-delivers-solid-Q1-2025-results-exceeding-outlook-will-seek-shareholder-approval-to-initiate-a-dividend-and-new-%24500-mn-repurchase
07 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250507324807/en/QIAGEN-to-Propose-Initiation-of-Annual-Cash-Dividend-for-Shareholder-Approval-at-Annual-General-Meeting
29 Apr 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250429803061/en/QIAGEN-Expands-Its-Digital-PCR-Portfolio-With-New-Lentivirus-Solutions-to-Strengthen-Cell-and-Gene-Therapy-Quality-Control
ABOUT THIS PAGE
Qiagen is a supplier offers 2 products (APIs, Excipients or Intermediates).
Find a price of NI-NTA SUPERFLOW bulk offered by Qiagen
Find a price of QIAGEN NI-NTA AGAROSE bulk offered by Qiagen